Systems biology and proteomic analysis of cerebral cavernous malformation

References

• Zhang J, Clatterbuck RE, Rigamonti D, Dietz HC. Mutations in KRIT1 in familial cerebral cavernous malformations. Neurosurgery 2000;46(5):1272-1277; discussion 1277-1279
   PubMed Web of Science ®Google Scholar
• Rigamonti D, Hadley MN, Drayer BP, et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 1988;319(6):343-7
   PubMed Web of Science ®Google Scholar
• Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system. Williams & Wilkins; Baltimore, MD, USA: 1989
   Google Scholar
• Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg 1991;75(5):709-14
   PubMed Web of Science ®Google Scholar
• Zabramski JM, Henn JS, Coons S. Pathology of cerebral vascular malformations. Neurosurg Clin N Am 1999;10(3):395-410
   PubMed Web of Science ®Google Scholar
• Bergametti F, Denier C, Labauge P, et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations. Am J Hum Genet 2005;76(1):42-51
   PubMed Web of Science ®Google Scholar
• Craig HD, Gunel M, Cepeda O, et al. Multilocus linkage identifies two new loci for a Mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 1998;7(12):1851-8
   PubMed Web of Science ®Google Scholar
• Dubovsky J, Zabramski JM, Kurth J, et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet 1995;4(3):453-8
   PubMed Web of Science ®Google Scholar
• Dupre N, Verlaan DJ, Hand CK, et al. Linkage to the CCM2 locus and genetic heterogeneity in familial cerebral cavernous malformation. Can J Neurol Sci 2003;30(2):122-8
   PubMed Web of Science ®Google Scholar
• Guclu B, Ozturk AK, Pricola KL, et al. Mutations in apoptosis-related gene, PDCD10, cause cerebral cavernous malformation 3. Neurosurgery 2005;57(5):1008-13
   PubMed Web of Science ®Google Scholar
• Liquori CL, Berg MJ, Siegel AM, et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 2003;73(6):1459-64
   PubMed Web of Science ®Google Scholar
• Borikova AL, Dibble CF, Sciaky N, et al. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype. J Biol Chem 2010;285(16):11760-4
   PubMed Web of Science ®Google Scholar
• Sahoo T, Johnson EW, Thomas JW, et al. Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 1999;8(12):2325-33
   PubMed Web of Science ®Google Scholar
• Serebriiskii I, Estojak J, Sonoda G, et al. Association of Krev-1/rap1a with KRIT1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 1997;15(9):1043-9
   PubMed Web of Science ®Google Scholar
• Zhang J, Clatterbuck RE, Rigamonti D, et al. Interaction between KRIT1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 2001;10(25):2953-60
   PubMed Web of Science ®Google Scholar
• Uhlik MT, Abell AN, Johnson NL, et al. Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat Cell Biol 2003;5(12):1104-10
   PubMed Web of Science ®Google Scholar
• Zawistowski JS, Stalheim L, Uhlik MT, et al. CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis. Hum Mol Genet 2005;14(17):2521-31
   PubMed Web of Science ®Google Scholar
• Crose LE, Hilder TL, Sciaky N, Johnson GL. Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells. J Biol Chem 2009;284(20):13301-5
   PubMed Web of Science ®Google Scholar
• Chen L, Tanriover G, Yano H, et al. Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3. Stroke 2009;40(4):1474-81
   PubMed Web of Science ®Google Scholar
• Zhang H, Ma X, Deng X, et al. PDCD10 interacts with STK25 to accelerate cell apoptosis under oxidative stress. Front Biosci 2012;17:2295-305
   Web of Science ®Google Scholar
• Gordon J, Hwang J, Carrier KJ, et al. Protein phosphatase 2a (PP2A) binds within the oligomerization domain of striatin and regulates the phosphorylation and activation of the mammalian Ste20-Like kinase Mst3. BMC Biochem 2011;12:54
   PubMed Web of Science ®Google Scholar
• Fidalgo M, Guerrero A, Fraile M, et al. Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress. J Biol Chem 2012;287(14):11556-65
   PubMed Web of Science ®Google Scholar
• Dibble CF, Horst JA, Malone MH, et al. Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate. PLoS One 2010;5(7):e11740
   Web of Science ®Google Scholar
• ProteomeXchange. Available from: http://proteomecentral.proteomexchange.org
   Google Scholar
• Peddinti D, Memili E, Burgess SC. Proteomics-based systems biology modeling of bovine germinal vesicle stage oocyte and cumulus cell interaction. PLoS One 2010;5(6):e11240
   Web of Science ®Google Scholar
• Gerling IC, Singh S, Lenchik NI, et al. New data analysis and mining approaches identify unique proteome and transcriptome markers of susceptibility to autoimmune diabetes. Mol Cell Proteomics 2006;5(2):293-305
   PubMed Web of Science ®Google Scholar
• Huang Y, Yan J, Lubet R, et al. Identification of novel transcriptional networks in response to treatment with the anticarcinogen 3H-1,2-dithiole-3-thione. Physiol Genomics 2006;24(2):144-53
   PubMed Web of Science ®Google Scholar
• Hilder TL, Malone MH, Bencharit S, et al. Proteomic identification of the cerebral cavernous malformation signaling complex. J Proteome Res 2007;6(11):4343-55
   PubMed Web of Science ®Google Scholar
• Bunai F, Ando K, Ueno H, Numata O. Tetrahymena eukaryotic translation elongation factor 1A (eEF1A) bundles filamentous actin through dimer formation. J Biochem 2006;140(3):393-9
   PubMed Web of Science ®Google Scholar
• Liu G, Tang J, Edmonds BT, et al. F-actin sequesters elongation factor 1alpha from interaction with aminoacyl-tRNA in a pH-dependent reaction. J Cell Biol 1996;135(4):953-63
   PubMed Web of Science ®Google Scholar
• Ejiri S. Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci Biotechnol Biochem 2002;66(1):1-21
   PubMed Web of Science ®Google Scholar
• Seo S, Baye LM, Schulz NP, et al. BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly. Proc Natl Acad Sci USA 2010;107(4):1488-93
   PubMed Web of Science ®Google Scholar
• Assinder SJ, Stanton JA, Prasad PD. Transgelin: an actin-binding protein and tumour suppressor. Int J Biochem Cell Biol 2009;41(3):482-6
   PubMed Web of Science ®Google Scholar
• Keshamouni VG, Jagtap P, Michailidis G, et al. Temporal quantitative proteomics by iTRAQ 2D-LC-MS/MS and corresponding mRNA expression analysis identify post-transcriptional modulation of actin-cytoskeleton regulators during TGF-beta-Induced epithelial-mesenchymal transition. J Proteome Res 2009;8(1):35-47
   PubMed Web of Science ®Google Scholar
• Alexander JS, Minagar A, Harper M, et al. Proteomic analysis of human cerebral endothelial cells activated by multiple sclerosis serum and IFNbeta-1b. J Mol Neurosci 2007;32(3):169-78
   PubMed Web of Science ®Google Scholar
• Huang Y, Shi H, Zhou H, et al. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 2006;107(9):3564-71
   PubMed Web of Science ®Google Scholar
• Schneider H, Errede M, Ulrich NH, et al. Impairment of tight junctions and glucose transport in endothelial cells of human cerebral cavernous malformations. J Neuropathol Exp Neurol 2011;70(6):417-29
   PubMed Web of Science ®Google Scholar
• Baev NI, Awad IA. Endothelial cell culture from human cerebral cavernous malformations. Stroke 1998;29(11):2426-34
   PubMed Web of Science ®Google Scholar
• Olk S, Turchinovich A, Grzendowski M, et al. Proteomic analysis of astroglial connexin43 silencing uncovers a cytoskeletal platform involved in process formation and migration. Glia 2010;58(4):494-505
   PubMed Web of Science ®Google Scholar
• Glading A, Han J, Stockton RA, Ginsberg MH. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell–cell junctions. J Cell Biol 2007;179(2):247-54
   PubMed Web of Science ®Google Scholar
• Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 2009;16(2):209-21
   PubMed Web of Science ®Google Scholar
• Gore AV, Lampugnani MG, Dye L, et al. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis Model Mech 2008;1(4-5):275-81
   PubMed Web of Science ®Google Scholar
• Whitehead KJ, Chan AC, Navankasattusas S, et al. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 2009;15(2):177-84
   PubMed Web of Science ®Google Scholar
• Gault J, Awad IA, Recksiek P, et al. Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery 2009;65(1):138-44. discussion 144-135
   PubMed Web of Science ®Google Scholar
• Vizcaino JA, Cote RG, Csordas A, et al. The proteomics identifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 2013;41(Database issue):D1063-9
   PubMed Web of Science ®Google Scholar